THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS.
D000818:Animals; D000900:Anti-Bacterial Agents; D000992:Antitoxins; D001414:Bacitracin; D002353:Carrier State; D004917:Erythromycin; D005667:Furunculosis; D006801:Humans; D007106:Immune Sera; D016233:Immunotherapy, Active; D008712:Methicillin; D009675:Novobiocin; D010019:Osteomyelitis; D010406:Penicillins; D011339:Probenecid; D013203:Staphylococcal Infections; D014116:Toxicology; D014118:Toxins, Biological; D014640:Vancomycin
D000900:Anti-Bacterial Agents; D000992:Antitoxins; D007106:Immune Sera; D010406:Penicillins; D014118:Toxins, Biological; D001414:Bacitracin; D009675:Novobiocin; D004917:Erythromycin; D014640:Vancomycin; D011339:Probenecid; D008712:Methicillin
ANTIBIOTICS; BACITRACIN; CARRIER STATE; ERYTHROMYCIN; FURUNCULOSIS; IMMUNE SERUMS; METHICILLIN; NOVOBIOCIN; OSTEOMYELITIS; PENICILLIN; PROBENECID; REVIEW; STAPHYLOCOCCAL INFECTIONS; TOXICOLOGIC REPORT; TOXINS AND ANTITOXINS; VACCINE THERAPY; VANCOMYCIN